These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 2128905)
1. Trends of T. cruzi infection based on data from blood bank screening. Zicker F; Martelli CM; de Andrade AL; Almeida e Silva S Rev Inst Med Trop Sao Paulo; 1990; 32(2):132-7. PubMed ID: 2128905 [TBL] [Abstract][Full Text] [Related]
2. Risk factors for Trypanosoma cruzi infection among blood donors in central Brazil. Martelli CM; Andrade AL; Silva SA; Zicker F Mem Inst Oswaldo Cruz; 1992; 87(3):339-43. PubMed ID: 1343642 [TBL] [Abstract][Full Text] [Related]
3. [Serological screening for Trypanosoma cruzi among blood donors in central Brazil]. de Andrade AL; Martelli CM; Luquetti AO; de Oliveira OS; Almeida e Silva S; Zicker F Bol Oficina Sanit Panam; 1992 Jul; 113(1):19-27. PubMed ID: 1642781 [TBL] [Abstract][Full Text] [Related]
4. Seropositivity for anti-trypanosoma cruzi antibodies among blood donors of the "Hospital Universitário Regional do Norte do Paraná", Londrina, Brazil. Reiche EM; Inouye MM; Pontello R; Morimoto HK; Itow Jankevicius S; Matsuo T; Jankevicius JV Rev Inst Med Trop Sao Paulo; 1996; 38(3):233-40. PubMed ID: 9163992 [TBL] [Abstract][Full Text] [Related]
5. Serologic screening for Trypanosoma cruzi among blood donors in central Brazil. de Andrade AL; Martelli CM; Luquetti AO; de Oliveira OS; Almeida e Silva S; Zicker F Bull Pan Am Health Organ; 1992; 26(2):157-64. PubMed ID: 1638280 [TBL] [Abstract][Full Text] [Related]
6. High prevalence anti-Trypanosoma cruzi antibodies, among blood donors in the State of Puebla, a non-endemic area of Mexico. Sánchez-Guillén MC; Barnabé C; Guégan JF; Tibayrenc M; Velásquez-Rojas M; Martínez-Munguía J; Salgado-Rosas H; Torres-Rasgado E; Rosas-Ramírez MI; Pérez-Fuentes R Mem Inst Oswaldo Cruz; 2002 Oct; 97(7):947-52. PubMed ID: 12471419 [TBL] [Abstract][Full Text] [Related]
7. [Parasitological and epidemiological aspects of Trypanosoma cruzi seropositive blood donors]. Galaz P; García S; Mercado R; Orrego E; Pagliero B; Contreras Mdel C; Salinas P; Arancibia C Rev Med Chil; 2007 Oct; 135(10):1291-5. PubMed ID: 18180836 [TBL] [Abstract][Full Text] [Related]
8. Prevalence of Trypanosoma Cruzi antibodies in blood donors from the Sao Paulo State, Brazil, between 2012 and 2014. Slavov SN; Otaguiri KK; Pinto MT; Valente VB; Ubiali EM; Covas DT; Kashima S J Infect Dev Ctries; 2017 Mar; 11(3):277-281. PubMed ID: 28368863 [TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of Trypanosoma cruzi infection among blood donors in the state of Bahia, Brazil. Miranda DLP; Ribeiro G; Lanza FC; Santos FLN; Reis RB; Fraga DBM; Silva LK; Silva Neto MMD; Santana IJ; Reis MGD Rev Soc Bras Med Trop; 2019 Aug; 52():e20190146. PubMed ID: 31390443 [TBL] [Abstract][Full Text] [Related]
10. Impact of one-time testing for Trypanosoma cruzi antibodies among blood donors in the United States. Dodd RY; Groves JA; Townsend RL; Notari EP; Foster GA; Custer B; Busch MP; Stramer SL Transfusion; 2019 Mar; 59(3):1016-1023. PubMed ID: 30588627 [TBL] [Abstract][Full Text] [Related]
11. Update on seroprevalence of anti-Trypanosoma cruzi antibodies among blood donors in northeast Mexico. Galavíz-Silva L; Molina-Garza DP; González-Santos MA; Mercado-Hernández R; González-Galavíz JR; Rosales-Encina JL; Molina-Garza ZJ Am J Trop Med Hyg; 2009 Sep; 81(3):404-6. PubMed ID: 19706904 [TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of Trypanosoma cruzi infection among unskilled urban workers in central Brazil. Zicker F; Oliveira RM; Luquetti AO; Oliveira OS; Smith PG Trans R Soc Trop Med Hyg; 1989; 83(4):511-3. PubMed ID: 2515628 [TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of Trypanosoma cruzi infection in at-risk blood donors in Catalonia (Spain). Piron M; Vergés M; Muñoz J; Casamitjana N; Sanz S; Maymó RM; Hernández JM; Puig L; Portús M; Gascón J; Sauleda S Transfusion; 2008 Sep; 48(9):1862-8. PubMed ID: 18522707 [TBL] [Abstract][Full Text] [Related]
14. Chagas Disease Control Programme in Brazil: a study of the effectiveness of 13 years of intervention. Costa FC; Vitor RW; Antunes CM; Carneiro M Bull World Health Organ; 1998; 76(4):385-91. PubMed ID: 9803589 [TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of Trypanosoma cruzi infection and vector control activities in rural communities of the southern Gran Chaco (Argentina). Moreno ML; Moretti E; Basso B; Céspedes MF; Catalá SS; Gorla DE Acta Trop; 2010 Mar; 113(3):257-62. PubMed ID: 19945420 [TBL] [Abstract][Full Text] [Related]
16. Seroprevalence and geographical distribution of sero-positive blood donors to Trypanosoma cruzi at the central blood bank of the National Medical Center "La Raza". González-Guzmán S; Paredes-Cervantes V; Bagu ET; Crescencio-Trujillo JA; Guerra-Marquez Á; Rivas N; Alejandre-Aguilar R; Bermúdez-Torres E; González-Cano P Transfusion; 2019 Feb; 59(2):639-647. PubMed ID: 30520031 [TBL] [Abstract][Full Text] [Related]
18. Blood transfusion and iatrogenic risks in Mexico City. Anti-Trypanosoma cruzi seroprevalence in 43,048 blood donors, evaluation of parasitemia, and electrocardiogram findings in seropositive. Hernández-Becerril N; Mejía AM; Ballinas-Verdugo MA; Garza-Murillo V; Manilla-Toquero E; López R; Trevethan S; Cardenas M; Reyes PA; Hirayama K; Monteón VM Mem Inst Oswaldo Cruz; 2005 Apr; 100(2):111-6. PubMed ID: 16021296 [TBL] [Abstract][Full Text] [Related]
19. The early implementation of Trypanosoma cruzi antibody screening of donors and donations within England: preempting a problem. Kitchen AD; Hewitt PE; Chiodini PL Transfusion; 2012 Sep; 52(9):1931-9. PubMed ID: 22414025 [TBL] [Abstract][Full Text] [Related]